SCHEMBL10075449

SCHEMBL10075449

N#C/N=C1\c2ccccc2-c2nc(-c3ccc(F)cc3)c(-c3ccc(F)cc3)nc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.41
ADORA2A P29274 3/20 0.41
MAPK10 P53779 1/20 0.40
MAPK14 Q16539 1/20 0.40
USP8 P40818 5/20 0.38
ADORA2B P29275 1/20 0.38
MYC P01106 1/20 0.37
WDR5 P61964 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ERBB2 P04626 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
MAOB P27338 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12248169 0.97 ADORA1 (0.43) ADORA1ADORA2AMAPK10MAPK14ADORA2B
SCHEMBL12226943 0.87 ADORA1 (0.36) ADORA1ADORA2AMAPK10MAPK14USP8
SCHEMBL12247602 0.86 ERBB2 (0.42) ADORA1ADORA2AMAPK10MAPK14ADORA2B
SCHEMBL10075463 0.85 IDO1 (0.43) MAPK14USP8MEN1KMT2ANPC1
SCHEMBL10075462 0.85 MYC (0.40) MAPK14USP8MYCWDR5MEN1
SCHEMBL12248167 0.84 ADORA1 (0.34) ADORA1ADORA2AUSP8ADORA2BSQOR
SCHEMBL12247837 0.81 KIF11 (0.40) MAPK14MYCWDR5MEN1KMT2A
SCHEMBL12250290 0.80 ACHE (0.42) ADORA1ADORA2AMAPK10MAPK14ADORA2B
SCHEMBL12248170 0.79 ADORA1 (0.33) ADORA1ADORA2AUSP8ADORA2B
SCHEMBL10075448 0.78 MEN1 (0.36) ADORA1ADORA2AUSP8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119828-B2 Material for an organic electroluminescence device and an organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE AFF4, KCNH3, HCN4 ADORA1 2796/4885ADORA2A 4134/4885MAPK10 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.